These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6865970)

  • 1. Platelet MAO activity and high risk for psychopathology in a German population.
    Propping P; Friedl W
    Mod Probl Pharmacopsychiatry; 1983; 19():304-14. PubMed ID: 6865970
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet MAO activity: relationships to clinical and psychometric variables.
    Adler SA; Gottesman II; Orsulak PJ; Kizuka PP; Schildkraut JJ
    Schizophr Bull; 1980; 6(2):226-31. PubMed ID: 7375854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet monoamine oxidase in healthy subjects: the "biochemical high-risk paradigm" revisited.
    Propping P; Rey ER; Friedl W; Beckmann H
    Arch Psychiatr Nervenkr (1970); 1981; 230(3):209-19. PubMed ID: 7295010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological high-risk paradigm and platelet MAO activity in community samples.
    Buchsbaum MS; Coursey RD
    Mod Probl Pharmacopsychiatry; 1983; 19():278-86. PubMed ID: 6865969
    [No Abstract]   [Full Text] [Related]  

  • 5. Low platelet monoamine oxidase activity: a possible biochemical correlate of borderline schizophrenia.
    Baron M; Levitt M; Perlman R
    Psychiatry Res; 1980 Dec; 3(3):329-35. PubMed ID: 6936727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase activity in children and adolescents with psychiatric disorders.
    Young JG; Cohen DJ; Waldo MC; Feiz R; Roth JA
    Schizophr Bull; 1980; 6(2):324-33. PubMed ID: 7375865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet MAO-B, personality, and psychopathology.
    Ruchkin VV; Koposov RA; af Klinteberg B; Oreland L; Grigorenko EL
    J Abnorm Psychol; 2005 Aug; 114(3):477-82. PubMed ID: 16117585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological problems of using platelet MAO in psychiatric research.
    Demisch L; Kaczmarczyk P; Gebhart P
    Mod Probl Pharmacopsychiatry; 1983; 19():265-77. PubMed ID: 6865968
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet MAO activity and evoked potentials in the identification of subjects biologically at risk for psychiatric disorders.
    Coursey RD; Buchsbaum MS; Murphy DL
    Br J Psychiatry; 1979 Apr; 134():372-81. PubMed ID: 444787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamine-thyroid hormone interactions: I. Thyroid hormone and platelet MAO activity in psychiatrically disturbed children.
    Young JG; Feiz R; Roth JA; Waldo MC; Cohen DJ
    Schizophr Bull; 1982; 8(2):297-300. PubMed ID: 7112043
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.
    Propping P; Friedl W
    Psychopharmacology (Berl); 1979 Nov; 65(3):265-72. PubMed ID: 117498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological characteristics corresponding to low versus high platelet monoamine oxidase activity.
    Donnelly EF; Murphy DL; Waldman IN; Buchsbaum MS; Coursey RD
    Biol Psychiatry; 1979 Apr; 14(2):375-83. PubMed ID: 476225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-year follow-up of subjects and their families defined as at risk for psychopathology on the basis of platelet MAO activities. 2-year follow-up of low platelet MAO.
    Coursey RD; Buchsbaum MS; Murphy DL
    Neuropsychobiology; 1982; 8(1):51-6. PubMed ID: 7073872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic factors affecting monoamine oxidase activity.
    Sullivan JL; Coffey CE; Sullivan PD; Taska R; Mahorney S; Cavenar JO
    Schizophr Bull; 1980; 6(2):308-13. PubMed ID: 7375863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric vulnerability, monoamine oxidase, and the average evoked potential.
    Haier RJ; Buchsbaum MS; Murphy DL; Gottesman II; Coursey RD
    Arch Gen Psychiatry; 1980 Mar; 37(3):340-5. PubMed ID: 7362421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological characteristics of subjects identified by platelet MAO activity and evoked potentials as biologically at risk for psychopathology.
    Coursey RD; Buchsbaum MS; Murphy DL
    J Abnorm Psychol; 1980 Apr; 89(2):151-64. PubMed ID: 7365128
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet monoamine oxidase B: use and misuse.
    Youdim MB
    Experientia; 1988 Feb; 44(2):137-41. PubMed ID: 3278920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelet monoamine oxidase--a useful enzyme in the study of psychiatric disorders?
    Fowler CJ; Tipton KF; MacKay AV; Youdim MB
    Neuroscience; 1982 Jul; 7(7):1577-94. PubMed ID: 6956813
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?
    Fleissner A; Seifert R; Schneider K; Eckert W; Fuisting B
    Eur Arch Psychiatry Neurol Sci; 1987; 237(1):8-15. PubMed ID: 3480800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology.
    Whitfield JB; Pang D; Bucholz KK; Madden PA; Heath AC; Statham DJ; Martin NG
    Psychol Med; 2000 Mar; 30(2):443-54. PubMed ID: 10824664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.